WHO backs Paxlovid for high-risk COVID patients

Apr 22, 2022

Also, the WHO revised its assessment of remdesivir, recommending it for mild or moderate infections in high-risk groups.

Lisa Schnirring | News Editor | CIDRAP NewsApr 22, 2022Also, the WHO revised its assessment of remdesivir, recommending it for mild or moderate infections in high-risk groups.Read More

Leave a Reply

Your email address will not be published.